Carewell Steuart Pharma Private Limited

Carewell Steuart Pharma Private Limited - pharma in Tiruvallur, Tamil Nadu, India. FY 2026 financials & compliance.
CIN U74990TN2008PTC070035 Incorporated 01 December 2008 ROC Chennai HQ Tiruvallur, Tamil Nadu, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹24.5 Cr
▲ 79% YoY
Net profit · FY 2025
₹77.47 Lakh
Net margin 3.2%
EBITDA · FY 2025
₹1.96 Cr
EBITDA margin 8%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹2 Cr
Issued & subscribed
Open charges
₹12.05 Cr
Satisfied ₹5.5 Cr
Company age
18 yrs
Est. 2008
Employees · EPFO
29
Provident fund records

About Carewell Steuart Pharma Private Limited

Data last updated:

Carewell Steuart Pharma Private Limited is a private limited company based in Tiruvallur, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 December 2008 and has been in existence for over 18 years.

The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U74990TN2008PTC070035. Its GSTIN is 33AADCC5333Q1ZH (Tamil Nadu).

The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹2 Cr. It is led by directors including Chandrasekaran Venkatarayalu (Managing Director) and Narasimhan Dhandapani.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Tiruvallur, Tamil Nadu.

As per the financials filed for FY 2025, the company reported a revenue of ₹24.5 Cr, a growth of 79% compared to the previous year. For the same year it recorded a net profit of ₹77.47 Lakh (net margin 3.2%) and EBITDA of ₹1.96 Cr (EBITDA margin 8%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 6% over five years.

The company has about 29 employees on its provident fund (EPFO) records.

As per MCA filings, the company has open charges of ₹12.05 Cr and satisfied charges of ₹5.5 Cr on record. Court records list 3 cases involving the company, including 1 filed by the company and 2 filed against it.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U74990TN2008PTC070035
Registration Number 070035
Incorporation Date 01 December 2008
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Contact details

Carewell Steuart Pharma Private Limited's registered office is in Tiruvallur, Tamil Nadu. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Plot No. G – 24 SIDCO, Kakkalur Industrial Estate Putlur Village Thiruvallur District, Tiruvallur, Tamil Nadu, India – 602003
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Carewell Steuart Pharma Private Limited, buy the company report.

Comprehensive company report
Carewell Steuart Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Carewell Steuart Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Carewell Steuart Pharma Private Limited, buy the company report.

Financials of Carewell Steuart Pharma Private Limited

FY 2025 filings available

Carewell Steuart Pharma Private Limited reported revenue of ₹24.5 Cr (up 79% YoY) for FY 2025.

Revenue · FY 2025
₹24.5 Cr ▲ 79%
Net profit · FY 2025
₹77.47 Lakh margin 3.2%
EBITDA · FY 2025
₹1.96 Cr margin 8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 79%
3 years · compounded
▲ 11%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 110%
3 years · compounded
▲ 69%
5 years · compounded
▼ 4%

Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 79% growth in the latest year. EBITDA rose 110% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹1.96 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹77.47 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin8%
Net Profit Margin3.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Carewell Steuart Pharma Private Limited, buy the company report.

Board of directors of Carewell Steuart Pharma Private Limited

Carewell Steuart Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Narasimhan DhandapaniDirector01 Dec 200817 Years 11 MonthsCurrent
Chandrasekaran VenkatarayaluManaging Director01 Dec 200817 Years 11 MonthsCurrent
Dhandapani LokeshAdditional Director24 Jan 20260 Years 9 MonthsCurrent

Peer comparison

Carewell Steuart Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Evinz Drugs Private Limited₹24.63 Cr (FY 2020)5.0%Hyderabad, Telangana, India
Pharlink Labs Private Limited₹24.56 Cr (FY 2024)111.0%Chennai, Tamil Nadu, India
Remidex Pharma Private Limited₹24.56 Cr (FY 2025)-22.0%Bengaluru, Karnataka, India
Carewell Steuart Pharma Private Limitedthis company₹24.5 Cr (FY 2025)₹77.47 Lakh3.2%79.0%29Tiruvallur, Tamil Nadu, India
MRHM Pharma Private Limited₹24.46 Cr (FY 2024)10.0%Bangalore, Karnataka, India
Sunberg Life Sciences Private Limited₹24.43 Cr (FY 2025)92.0%Chennai, Tamil Nadu, India
Axon Drugs Private Limited₹24.4 Cr (FY 2024)4.0%Chennai, Tamil Nadu, India
Kemecos India Pvt Ltd₹24.35 Cr (FY 2025)4.0%Kolkata, West Bengal, India

To see the full peer comparison of Carewell Steuart Pharma Private Limited, buy the company report.

Auditor

Carewell Steuart Pharma Private Limited is audited by A. S. V. S. AND CO. LLP for the financial year 2019.

Auditor firmFinancial yearFirm registration number
A. S. V. S. AND CO. LLPFY 2019009840S/S200077

Shareholding

The shareholding of Carewell Steuart Pharma Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Carewell Steuart Pharma Private Limited, buy the company report.

Charges & borrowings

Open charges
₹12.05 Cr
Satisfied charges
₹5.5 Cr
Breakdown by lending institutions
Sidbi₹12.05 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
16 Apr 2025101084447Sidbi₹7.2 CrOpen
09 Mar 2023100709869Sidbi₹4.85 CrOpen
06 Sep 2022100645830Indian Bank₹2.3 CrSatisfied
15 Dec 201110326380Indian Bank₹20 LakhSatisfied
04 Feb 201010203284Indian Bank₹3 CrSatisfied

To see the full charge records of Carewell Steuart Pharma Private Limited, buy the company report.

Total charge records: 5 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Carewell Steuart Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Carewell Steuart Pharma Private Limited has a workforce of 29 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.

Employee count
29
Active EPFO establishments
1
Employee growth
-23.68%

GST

Carewell Steuart Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
33AADCC5333Q1ZHTamil NaduActive01 Jul 2017

To see the full GST registrations and return filing status of Carewell Steuart Pharma Private Limited, buy the company report.

Recent activity

Carewell Steuart Pharma Private Limited has 4 board changes on record since 2008: 3 appointments and 1 cessation. The latest: Dhandapani Lokesh was appointed as Additional Director on 24 Jan 2026.

Appointed
Dhandapani Lokesh was appointed as Additional Director.
AGM
Carewell Steuart Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge registered on 15 Dec 2011 via Charge ID 10326380 with Indian Bank was fully satisfied on 17 Apr 2025.
Charges
A charge registered on 04 Feb 2010 via Charge ID 10203284 with Indian Bank was fully satisfied on 17 Apr 2025.
Charges
A charge with Sidbi amounted to Rs. 7.20 Cr with Charge ID 101084447 was registered on 16 Apr 2025.
Charges
A charge registered on 06 Sep 2022 via Charge ID 100645830 with Indian Bank was fully satisfied on 08 Apr 2025.
Filing
Carewell Steuart Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Charges
A charge with Sidbi amounted to Rs. 4.85 Cr with Charge ID 100709869 was registered on 09 Mar 2023.
Charges
A charge with Indian Bank amounted to Rs. 2.30 Cr with Charge ID 100645830 was registered on 06 Sep 2022.
Charges
A charge with Indian Bank of Rs. 3.00 Cr registered on 04 Feb 2010 with Charge ID 10203284 was modified on 31 Aug 2015.
Charges
A charge with Indian Bank amounted to Rs. 0.20 Cr with Charge ID 10326380 was registered on 15 Dec 2011.
Charges
A charge with Indian Bank amounted to Rs. 3.00 Cr with Charge ID 10203284 was registered on 04 Feb 2010.

4 earlier events are in the company report.

Frequently asked questions

Carewell Steuart Pharma is an active private limited company based in Tiruvallur, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 December 2008 (18+ years old) and is registered under CIN U74990TN2008PTC070035.

Carewell Steuart Pharma has 3 current directors:

The latest financial statements of Carewell Steuart Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Carewell Steuart Pharma is 33AADCC5333Q1ZH, registered in Tamil Nadu.

The CIN (Corporate Identification Number) of Carewell Steuart Pharma is U74990TN2008PTC070035. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Carewell Steuart Pharma has 3 court cases on record: 1 filed by the company and 2 filed against it.

Carewell Steuart Pharma was incorporated on 01 December 2008, making it 18+ years old. It is registered with the Registrar of Companies, Chennai.

The peers of Carewell Steuart Pharma by revenue are Evinz Drugs Private Limited, Pharlink Labs Private Limited, Remidex Pharma Private Limited, MRHM Pharma Private Limited, Sunberg Life Sciences Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Dhandapani Lokesh was appointed as Additional Director on 24 Jan 2026. Chandrasekaran Venkatarayalu ceased to be Director on 09 Jan 2009. Chandrasekaran Venkatarayalu was appointed as Managing Director on 01 Dec 2008. Carewell Steuart Pharma has 4 board changes on record in total.

The registered office of Carewell Steuart Pharma is at Plot No. G – 24 SIDCO, Kakkalur Industrial Estate Putlur Village Thiruvallur District, Tiruvallur, Tamil Nadu, India – 602003.

Carewell Steuart Pharma operates in the pharma industry, in the drug formulation and development segment.